| Literature DB >> 35275514 |
M Helgesson1, S Rahman1, E Björkenstam1,2, K Gustafsson1, R Amin1, H Taipale1,3,4, A Tanskanen3, L Ekselius2, E Mittendorfer-Rutz1.
Abstract
AIMS: Labour market marginalisation (LMM), i.e. severe problems in finding and keeping a job, is common among young adults with attention-deficit/hyperactivity disorder (ADHD). This study aimed to disentangle the extent of LMM as well as the heterogeneity in patterns of LMM among young adults with ADHD and what characterises those belonging to these distinct trajectories of LMM.Entities:
Keywords: ADHD; attention-deficit/hyperactivity disorder; labour market marginalisation; sick leave
Mesh:
Year: 2021 PMID: 35275514 PMCID: PMC8546500 DOI: 10.1017/S2045796021000536
Source DB: PubMed Journal: Epidemiol Psychiatr Sci ISSN: 2045-7960 Impact factor: 6.892
Characteristics at baseline for the 6287 individuals, 22–29 years, diagnosed with attention deficit/hyperactivity disorder (ADHD) in adult age between 2006 and 2011
| Sex | |
| Men | 3556 (56.6) |
| Women | 2731 (43.4) |
| Age | |
| 22–24 years | 2653 (42.2) |
| 25–29 years | 3634 (57.8) |
| Educational level | |
| Low (0–9 years) | 2869 (45.6) |
| Medium (10–12 years) | 2795 (44.5) |
| High (>12 years) | 623 (9.9) |
| Family composition | |
| Married/living together without child at home | 112 (1.8) |
| Married/living together with child at home | 623 (9.9) |
| Single without child at home | 5078 (80.8) |
| Single with child at home | 474 (7.5) |
| Type of living area | |
| Big cities | 1987 (31.6) |
| Medium cities | 2442 (38.8) |
| Small cities/villages | 1858 (29.6) |
| Region of birth | |
| Sweden | 5736 (91.2) |
| Nordic countries | 45 (0.7) |
| EU27 | 64 (1.0) |
| Other countries | 442 (7.0) |
| Unemployment | |
| No days | 3759 (59.8) |
| 1–180 days | 1629 (25.9) |
| >180 days | 899 (14.3) |
| Sickness absence | |
| No days | 5009 (79.7) |
| 1–90 days | 419 (6.7) |
| >90 days | 859 (13.7) |
| Mental comorbidities | |
| Depression/Bipolar disorder | 1632 (26.0) |
| Anxiety/Stress-related disorders | 1979 (31.5) |
| Autism spectrum disorder | 666 (10.6) |
| Substance use | 1300 (20.7) |
| Behavioural/Emotional disorders | 207 (3.3) |
| Schizophrenia/Psychoses | 210 (3.3) |
| Mental retardation | 214 (3.4) |
| Other mental disorders | 1149 (18.3) |
| Somatic comorbidities | |
| Musculoskeletal disorders | 358 (5.7) |
| Asthma/Diabetes | 127 (2.0) |
| Accidents | 738 (11.7) |
| Other somatic disorders | 2532 (40.3) |
| ADHD-medication | |
| Yes | 3258 (51.8) |
| No | 3029 (48.2) |
| Subtype of hyperactivity disorder | |
| Attention deficit/hyperactivity disorder (ADHD) | 4927 (78.4) |
| Attention deficit disorder (ADD) | 615 (9.8) |
| Deficits in attention, motor control and perception (DAMP) | 57 (0.9) |
| Unspecified | 688 (10.9) |
Measured on 31st of December in the year preceding the diagnosis of ADHD between 2006 and 2011.
Missing education is considered to be low educational level.
Measured during the year preceding the first diagnosis of ADHD.
Measured during the same year as the diagnosis of ADHD due to following diagnoses in the International Classification of Diseases version 10 (ICD-10): Depression and Bipolar disorder (ICD-10: F30–F34), Anxiety and stress-related disorders (ICD-10: F40–F48), Autism spectrum disorder (ICD-10: F84), Substance use (ICD-10: F10–F19 and ATC: N07B), Behavioural and Emotional disorders (ICD-10: F91–F98), Schizophrenia/Psychoses (ICD-10: F20–F29), Mental retardation (ICD-10: F70–F83, F85–F89), Other mental disorders (ICD-10: Other F), Musculoskeletal diseases (ICD-10: M01–M99), Asthma (ICD-10: J45), Diabetes Mellitus (ICD-10: E10–E11 and ATC: A10), Neoplasms (ICD-10: C00–D48), Cardiovascular diseases (ICD-10: I00–I99), Accidents (S00–S99) and Other somatic diseases (ICD-10: other codes except O.80 and Z00–99).
Measured during the year after the diagnosis of ADHD.
Fig. 1.Trajectory groups of labour market marginalisation (LMM) among young adults diagnosed with attention-deficit hyperactivity disorder (ADHD, n = 6287).
Adjusted odds ratios (OR) and 95% confidence intervals (CI) for belonging to each trajectory group of labour market marginalisation (LMM) compared to the reference group (constant low trajectory of LMM) among the individuals aged 22–29 years and registered in Sweden, with an incident diagnosis of attention-deficit hyperactivity disorder (ADHD) 2006–2011 (n = 6287)
| Moderately decreasing | Moderately increasing | Fluctuating | Rapidly increasing | Increasing high | ||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | Log-likelihood test ( | |
| Sex | ||||||
| Men | 1 | 1 | 1 | 1 | 1 | 47.1 (<0.0001) |
| Women | 0.81 (0.65–1.01) | 0.93 (0.76–1.14) | 0.85 (0.67–1.07) | 1.03 (0.83–1.27) | ||
| Age | ||||||
| 22 –24 years (younger) | 1 | 1 | 1 | 1 | 1 | 118.9 (<0.0001) |
| 25–29 years (older) | 0.87 (0.71–1.07) | 0.84 (0.69–1.01) | 0.97 (0.80–1.19) | |||
| Educational level | ||||||
| Low (0–9 years) | 1.19 (0.96–1.49) | 294.2 (<0.0001) | ||||
| Medium (>9–12 years) | 1 | 1 | 1 | 1 | 1 | |
| High (>12 years) | ||||||
| Family composition | ||||||
| Married/living together without child at home | 0.95 (0.42–2.13) | 0.71 (0.33–1.54) | 1.57 (0.77–3.30) | 1.40 (0.70–2.89) | 1.23 (0.61–2.58) | 47.7 (<0.0001) |
| Married/ living together with child home | 0.87 (0.62–1.21) | 0.90 (0.67–1.21) | 0.78 (0.55–1.09) | 1.03 (0.75–1.40) | ||
| Single without child | 1 | 1 | 1 | 1 | 1 | |
| Single with child | 1.22 (0.77–1.92) | 1.46 (0.94–2.29) | 1.08 (0.71–1.65) | |||
| Type of living area | ||||||
| Big cities | 1 | 1 | 1 | 1 | 1 | 72.3 (<0.0001) |
| Medium cities | ||||||
| Small cities/villages | ||||||
| Region of birth | ||||||
| Sweden | 1 | 1 | 1 | 1 | 1 | 28.5 (0.0186) |
| Nordic countries | 0.68 (0.19–2.34) | 0.87 (0.31–2.64) | 0.85 (0.29–2.66) | 1.14 (0.40–3.58) | ||
| EU27 | 0.35 (0.09–1.05) | 0.94 (0.42–2.14) | 0.83 (0.31–2.13) | 0.87 (0.37–2.11) | 0.62 (0.24–1.58) | |
| Other countries | 1.09 (0.70–1.69) | 1.41 (0.97–2.10) | ||||
| Comorbidities | ||||||
| Depression/Bipolar disorder | 34.2 (<0.0001) | |||||
| Anxiety/Stress-related disorders | 1.24 (0.98–1.57) | 59.1 (<0.0001) | ||||
| Autism spectrum disorder | 1.37 (0.85–2.24) | 1.48 (0.96–2.32) | 292.8 (<0.0001) | |||
| Substance use | 0.88 (0.67–1.16) | 36.5 (<0.0001) | ||||
| Behavioural/Emotional disorders | 0.69 (0.32–1.48) | 1.11 (0.60–2.14) | 1.27 (0.65–2.55) | 17.3 (0.0040) | ||
| Schizophrenia/Psychoses | 1.21 (0.40–4.05) | 1.91 (0.75–5.88) | 2.40 (0.90–7.57) | 104.8 (<0.0001) | ||
| Mental retardation | 0.89 (0.41–1.94) | 0.78 (0.39–1.64) | 0.95 (0.43–2.12) | 1.43 (0.75–2.88) | 76.4 (<0.0001) | |
| Other mental disorders | 1.09 (0.80–1.50) | 1.24 (0.94–1.66) | 103.6 (<0.0001) | |||
| Musculoskeletal disorders | 0.75 (0.46–1.21) | 1.12 (0.75–1.69) | 0.92 (0.57–1.47) | 1.18 (0.78–1.81) | 1.15 (0.75- 1.79) | 6.1 (0.2981) |
| Asthma/Diabetes | 1.25 (0.50–3.28) | 1.26 (0.55–3.11) | 2.04 (0.95–4.93) | 9.0 (0.1103) | ||
| Accidents | 1.12 (0.80–1.57) | 1.26 (0.92–1.73) | 1.03 (0.74–1.45) | 11.0 (0.0506) | ||
| Other somatic disorders | 1.07 (0.87–1.33) | 1.18 (0.97–1.44) | 0.91 (0.73–1.14) | 1.17 (0.95–1.43) | 1.17 (0.95–1.44) | 10.3 (0.0678) |
| ADHD-medication | ||||||
| No | 1 | 1 | 1 | 1 | 1 | 31.9 (<0.0001) |
| Yes | 1.10 (0.90–1.34) | 1.00 (0.83–1.20) | 0.89 (0.73–1.10) | 0.97 (0.80–1.17) | ||
| Subtype of hyper-activity disorder | ||||||
| ADHD | 1 | 1 | 1 | 1 | 1 | 22.2 (0.1025) |
| Attention deficit disorder (ADD) | 1.01 (0.70–1.45) | 1.14 (0.83–1.58) | 1.27 (0.89–1.82) | 1.32 (0.95–1.86) | ||
| Deficits in attention, motor control and perception (DAMP) | 2.33 (0.68–10.64) | 1.66 (0.50–7.49) | 0.30 (0.02–2.36) | 2.69 (0.84–11.95) | 2.94 (0.95–12.91) | |
| Unspecified | 0.94 (0.68–1.31) | 0.86 (0.64–1.17) | 0.78 (0.55–1.10) | 1.11 (0.82–1.51) | 1.04 (0.77–1.42) | |
All ORs were mutually adjusted for all other variables.
χ2 statistics from the log-likelihood test (p-value) derived by multinomial logistic regression.
Significant associations are in bold text.
Reference group regarding all comorbidities were those without the respective health condition.
All somatic disorders except musculoskeletal diseases, asthma, diabetes, or accidents.
Measured during the year after the diagnosis of ADHD.